| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis
|
Sacha, Tomasz
|
|
2003
|
27 |
12 |
p. 1163-1166
4 p.
|
artikel
|
| 2 |
Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells
|
Reid, Gregor S.D.
|
|
2003
|
27 |
12 |
p. 1135-1142
8 p.
|
artikel
|
| 3 |
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study
|
Cherry, Athena M.
|
|
2003
|
27 |
12 |
p. 1085-1090
6 p.
|
artikel
|
| 4 |
Conference:1st ISC Cancer Conference 2004
|
|
|
2003
|
27 |
12 |
p. 1173-
1 p.
|
artikel
|
| 5 |
Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia
|
Cheong, June-Won
|
|
2003
|
27 |
12 |
p. 1159-1162
4 p.
|
artikel
|
| 6 |
Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard arm
|
Hills, R.K.
|
|
2003
|
27 |
12 |
p. 1071-1073
3 p.
|
artikel
|
| 7 |
Corrigendum to “Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation aggregation of FcεRI or FcγRI” [Leuk. Res. 27 (2003) 677–682]
|
Kirshenbaum, Arnold S.
|
|
2003
|
27 |
12 |
p. 1171-
1 p.
|
artikel
|
| 8 |
Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia
|
Özgen, Ünsal
|
|
2003
|
27 |
12 |
p. 1109-1113
5 p.
|
artikel
|
| 9 |
Editor’s comment
|
Bennett, J.M
|
|
2003
|
27 |
12 |
p. 1169-
1 p.
|
artikel
|
| 10 |
Effects of lower dose of imatinib to CML patients
|
Horikoshi, Akira
|
|
2003
|
27 |
12 |
p. 1167-
1 p.
|
artikel
|
| 11 |
In vitro antileukemic effect of a new anthracycline analogue, MEN 11079
|
Biscardi, Monica
|
|
2003
|
27 |
12 |
p. 1125-1134
10 p.
|
artikel
|
| 12 |
In vitro proliferative and differentiating characteristics of CD133+ and CD34+ cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO)
|
Dimitriou, Helen
|
|
2003
|
27 |
12 |
p. 1143-1151
9 p.
|
artikel
|
| 13 |
Low dose daily rhGM–CSF application activates monocytes and dendritic cells in vivo
|
Demir, Gokhan
|
|
2003
|
27 |
12 |
p. 1105-1108
4 p.
|
artikel
|
| 14 |
Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia
|
Kollia, Panagoula
|
|
2003
|
27 |
12 |
p. 1101-1103
3 p.
|
artikel
|
| 15 |
Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
|
Giles, Francis J.
|
|
2003
|
27 |
12 |
p. 1077-1083
7 p.
|
artikel
|
| 16 |
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
|
Giles, Francis J.
|
|
2003
|
27 |
12 |
p. 1091-1096
6 p.
|
artikel
|
| 17 |
Relationship between cyclin D1 and p21Waf1/Cip1 during differentiation of human myeloid leukemia cell lines
|
Ullmannová, Veronika
|
|
2003
|
27 |
12 |
p. 1115-1123
9 p.
|
artikel
|
| 18 |
Ribonucleotide reductase: an old target with new potential
|
Smith, B.Douglas
|
|
2003
|
27 |
12 |
p. 1075-1076
2 p.
|
artikel
|
| 19 |
Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma
|
Xiros, Nikolaos
|
|
2003
|
27 |
12 |
p. 1097-1099
3 p.
|
artikel
|
| 20 |
Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential
|
Ramı́rez, Manuel
|
|
2003
|
27 |
12 |
p. 1153-1157
5 p.
|
artikel
|
| 21 |
Volume 27 contents and author index
|
|
|
2003
|
27 |
12 |
p. I-XXII
nvt p.
|
artikel
|
Tijdschrift beschrijving